Published in Vaccine Weekly, February 22nd, 2006
Researchers in Turkey report, "The aim of this study was to compare serum levels of tetanus antibody in diabetic patients over 50 years of age with those of age-and sex-matched non-diabetic controls."
Ali Tamer at Izzet Baysal Medical School and collaborators explained, "The study population consisted of 115 type 2 diabetic patients and 115 age- and sex-matched nondiabetic patients. Serum levels of tetanus IgG were measured by a commercial ELISA kit, and levels over 0.1 IU/mL were considered protective."
"Mean serum levels of tetanus antibody in the diabetic and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.